Abstract. Renal failure is observed in the pathological progression of sepsis and septic shock. Renal mesangial cells (RMCs) have been implicated in renal failure as a result of producing mediators, such as monocyte chemoattractant protein-1 (MCP-1) in response to lipopolysaccharide (LPS). Mitogen-activated protein kinases (MAPKs) have been demonstrated to mediate the LPS-induced inflammatory response in RMCs. Although previous studies indicated a promising effect of apocynin in various inflammatory conditions, its antiseptic efficacy in mesangial cells remains to be clearly determined. In the present study, the anti-inflammatory effects of apocynin and its underlying mechanism were examined in LPS-challenged RMCs. Apocynin significantly inhibited nitric oxide (NO) production in LPS-challenged RMCs and the expression levels of inducible NO synthase and cyclooxygenase-2. In addition, the level of LPS-induced MCP-1 expression was significantly attenuated with apocynin. Furthermore, apocynin significantly suppressed the activation of MAPKs, such as extracellular signal-regulated kinases 1/2 and p38, but not c-Jun N-terminal kinases. Apocynin exhibited significantly increased expression of heme oxygenase-1 (HO-1) induction via nuclear factor (erythroid-derived 2)-like-2 (Nrf-2) phosphorylation. Inhibition of HO-1 with zinc protoporphyrin significantly abolished apocynin-induced suppression of MCP-1, indicating that HO-1 is significant in the suppression of MCP-1. Thus, apocynin exerts antiseptic activity via the suppression of pro-inflammatory signaling pathways and the activation of cytoprotective signaling pathways, such as HO-1/Nrf-2 in RMCs, indicating that apocynin may present as a promising candidate for in vivo evaluation of a therapeutic agent for inflammation-associated renal disorders.
Introduction
Sepsis and septic shock are associated with systemic inflammatory response, and eventually lead to multiple organ dysfunctions and mortality (1) . The most common cause of sepsis is exposure to bacterial structural pathogens resulting in the excessive production of pro-inflammatory mediators, such as nitric oxide (NO) and cyclooxygenase-2 (COX-2), and cytokines, such as tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) by aberrant activation of multiple immune cells (1) . Renal mesangial cells (RMCs) within the glomerulus are significant in the pathogenesis of various types of renal disease (2) . Previous experimental studies have demonstrated that endotoxins activate RMCs (3) . Furthermore, RMCs produce sepsis-associated mediators, such as TNF-α and monocyte chemoattractant protein-1 (MCP-1) in response to lipopolysaccharide (LPS) (4) . MCP-1, a type of chemokine, contributes to the migration and infiltration of monocytes/macrophages in glomeruli under pathophysiological conditions (5) . Renal damage, such as glomerulonephritis, a systemic response to infection, occurs in critically ill sepsis and septic shock patients (6) . The increased expression level of MCP-1 was observed during the pathogenesis of renal disease models, such as LPS-induced septic kidney and LPS-challenged macrophage cells (7, 8) . Recently, aberrant production of pro-inflammatory mediators and cytokines has been demonstrated to be involved in the aggravation of kidney damage under septic conditions (9) . Our previous finding indicates that natural compounds possessing anti-inflammatory potential inhibit the expression levels of inducible NO synthase (iNOS) and COX-2, and the secretion of TNF-α and IL-1β in LPS-challenged macrophages (10, 11) . In addition, it has been reported that mesangial cells protect themselves from the LPS-induced overproduction of COX-2 by enhancing heme oxygenase-1 (HO-1) expression under septic conditions (7) . It is important to clearly understand the role of mesangial cells in sepsis given that they perform multiple roles during its progression. Therefore, suppression of these pro-inflammatory mediators and cytokines is useful for the treatment of inflammation-associated renal pathogenic conditions. Nuclear factor (erythroid-derived 2)-like-2 (Nrf-2) is the key transcription factor required for cellular defense against oxidative stress. It has been reported that Nrf-2 exerts cytoprotective effects in septic mice models (12) . Caffeic acid phenethyl ester (CAPE) has been reported to contribute to the regulation of peripheral immune functions, expressing HO-1 via the regulation of Nrf-2, a major transcription factor of HO-1 (13) . HO-1 is induced by a number of oxidative stresses and exhibits a key cytoprotective role against oxidative cellular injuries. Recent studies have indicated that LPS-challenged macrophages protect themselves from overproduction of inflammatory mediators, such as COX-2 by enhancing HO-1 expression levels (14) . In addition, it has been reported that HO-1 inhibits the excessive production of cytokines, such as TNF-α in LPS-challenged RAW264.7 cells (15) . Furthermore, HO-1 induction improved animal survival in lethal endotoxemia (12) . The evidence indicated that upregulation of HO-1 is associated with significant activation of mitogen-activated protein kinases (MAPKs) and Nrf-2 in animal cells (16) .
Apocynin (4-hydroxy-3-methoxyacetophenone), originally isolated from the root extract of Himalayan herb, Picrorhiza kurroa Royle (Scrophulariaceae), inhibits the production of superoxide by generating NADPH oxidase enzyme (17) . The aim of the present study was to gain novel insight into the anti-inflammatory properties of apocynin in RMCs given that previous studies demonstrated that apocynin exhibits various pharmacological properties, such as in the pathogenesis of inflammatory skin diseases (18) , ulcerative colitis (19), hyperoxaluria-induced nephrolithiasis (20) and acute lung injury (21) , and is beneficial for the treatment of osteoarthritis and rheumatoid arthritis (22) . The anti-inflammatory mechanisms of apocynin in RMCs are yet to be identified. Therefore, in the present study, the possible protective effect of apocynin and its underlying mechanisms were investigated in LPS-challenged RMCs.
Materials and methods
Reagents and cell culture. Bacterial LPS from Escherichia coli serotype 055: B5 and apocynin (4'-hydroxy-3'-methoxyacetophenone) were purchased from Sigma-Aldrich (Merck KGaA, Darmstadt, Germany). Apocynin was dissolved in dimethyl sulfoxide and the desired concentration was added to the culture medium of rat mesangial cells, mentioned below. Rat kidney mesangial cells were obtained from the American Type Culture Collection (cat. no. CRL-2573; Manassas, VA, USA) and maintained in HyClone Dulbecco's modified Eagle's medium (GE Healthcare Life Sciences, Logan, UT, USA) supplemented with 15% fetal bovine serum, 100 U/ml penicillin, 100 mg/ml streptomycin (both from Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, USA) and 0.4 mg/ml G418 disulphate (Duchefa Biochemie, Haarlem, Netherlands) at 37˚C in 5% CO 2 . At ~75% confluence, mesangial cells were incubated with serum free media and treated with various concentrations of apocynin (62.5, 125, 250 and 500 µM).
Cell viability assay. The mesangial cells were seeded at 5x10 4 /well in 96-well plates and incubated at 37˚C under 5% Nitrite quantification assay. Accurate quantitative measurement of NO production in the biological samples was estimated by measuring the quantity of nitrite, a stable metabolite of NO, using the Griess assays. Subsequent to apocynin-pretreated RMCs being stimulated with LPS in at 5x10 5 /well in 12-well plates for 24 h, 100 µl cell supernatant was combined with an equal volume of Griess reagent (Sigma-Aldrich, St. Louis, MO, USA). The absorbance was measured at a wavelength of 550 nm using a microplate reader and sodium nitrite served as a standard. The results were expressed as the percentage of released NO from LPS-stimulated RMCs, and a standard curve was established.
Western blot analysis. The cells were seeded at 2.5x10 6 /well in 60-mm cell culture plates and pretreated with apocynin for 1 h. Following treatment, the cells were stimulated with LPS for various durations. Then the cells were washed with 1X phosphate-buffered saline and lysed in PRO-PREP lysis buffer (Intron Biotechnology, Inc., Seongnam, Korea). Samples from the cell lysates were denatured with sonication on ice and equal amounts of protein were separated on 10% sodium dodecyl sulfate (SDS)-polyacrylamide gel. Proteins were transferred to polyvinylidene fluoride membrane (Merck KGaA) and blocked in 5% skimmed milk or 3% bovine serum albumin (BSA) in Tris-buffered saline and Tween-20 (TBST) for 1 h at room temperature. The membranes were probed with specific antibodies against MCP-1 (1:1,000; cat. no. ab7202; Abcam, Cambridge, MA, USA), iNOS (1:1,000; cat. no. 610333, BD Transduction Laboratories, San Jose, CA, USA), COX-2 (1:1,000; cat. no. 48425; Cell Signaling Technology, Inc., Danvers, MA, USA), phosphorylated-Nrf2 (1:1,000; cat. no. bs-2013R; Bioss, Beijing, China), HO-1 (1:500; cat. no. ab13248; Abcam), Akt (cat. no. 9272), phosphorylated-Akt (cat. no. 9271), extracellular signal-regulated kinase 1/2 (Erk1/2) (cat. no. 4695), phosphorylated-Erk1/2 (cat. no. 9101), p38 (cat. no. 9212), phosphorylated-p38 (cat. no. 9211), phosphorylated-c-Jun N-terminal kinase (cat. no. 9251), JNK (1:1,000; cat. no. 9252) (all from Cell Signaling Technology, Inc.), and β-actin (1:2,500; cat. no. A5441, Sigma-Aldrich; Merck KGaA) were diluted either in 5% skimmed milk or 3% BSA. After thoroughly washing with TBST, the membranes were incubated with horseradish peroxidase (HRP)-conjugated goat anti-rabbit IgG (1:2,500, cat. no. 111-035-144) for polyclonal antibodies, or with HRP-conjugated goat anti-mouse IgG secondary antibodies (1:2,500, cat. no. 715-035-150; Jackson ImmunoResearch Laboratories, West Groove, PA, USA). Immunoreactive bands were visualized using an enhanced X-ray film and intensity was measured by ImageQuant 5.2 (GE Healthcare, Waukesha, WI, USA). All values shown in the figures are expressed as the means ± standard deviation (SD) obtained from at least three independent experiments.
Statistical analysis. The experimental results are expressed as means ± SD obtained from at least three independent experiments. Statistical significance was analyzed by one-way ANOVA. P<0.05 was considered to indicate a statistically significant difference.
Results
Apocynin suppresses NO production in LPS-stimulated rat mesangial cells. The anti-inflammatory effects of apocynin were evaluated according to the quantity of NO production in LPS-stimulated RMCs by measuring the quantity of nitrite, a stable metabolite of NO, using Griess reagent. Cells were incubated with the indicated concentrations of apocynin (62.5, 125, 250 and 500 µM) for 1 h prior to LPS-treatment. The production of NO in RMCs was increased following LPS incubation for 24 h. However, apocynin significantly inhibited the production of NO in a concentration-dependent manner in LPS-stimulated RMCs (Fig. 1A) . Evaluation of the cytotoxicity using CCK-8 assay demonstrated that apocynin-induced cytotoxicity was negligible at concentrations up to 500 µM apocynin (Fig. 1B) .
Apocynin attenuates LPS-induced iNOS, COX-2 and MCP-1 expression levels in rat mesangial cells.
To investigate whether apocynin exhibits inhibitory activity against NO via inhibition of iNOS and COX-2, western blot analysis was performed. LPS treatment resulted in markedly increased expression levels of iNOS and COX-2 in response to LPS. However, pretreatment of apocynin significantly attenuated LPS-induced overproduction of iNOS and COX-2 protein in RMCs ( Fig. 2A-C) . These findings are consistent with the inhibitory effect of the fractions on NO release (Fig. 1A) . As MCP-1 is key in the migration of activated microphages, whether apocynin suppresses the LPS-attenuated expression level of MCP-1 was examined using western blot analysis. To examine the effect of apocynin on LPS-induced MCP-1, mesangial cells were pretreated with apocynin for ~1 h prior to LPS-treatment for 24 h. LPS-induced MCP-1 expression levels were significantly reduced by apocynin treatment in a concentration-dependent manner ( Fig. 2A and D) .
Effect of apocynin on LPS-induced phosphorylation of MAPKs in rat mesangial cells.
To examine the underlying mechanism by which apocynin exerts its anti-inflammatory effects, the MAPK signaling pathway, which is known to be significantly involved in pro-inflammatory responses, was examined. Cells were pretreated with apocynin at different concentrations for 1 h and subsequently treated with LPS (200 ng/ml) for 30 min. LPS treatment exhibited a robust activation of all three MAPKs (Fig. 3) . Apocynin treatment significantly attenuated the phosphorylation of Erk1/2 and p38 in a concentration-dependent manner (Fig. 3A-C) . By contrast, there was no noticeable inhibitory effect of apocynin on phosphorylation of JNK in LPS-induced RMCs (Fig. 3A and D) . The suppressive effect of apocynin on the LPS-induced activation of Erk1/2 and p38 signaling pathways strongly indicates that apocynin exerts significant anti-inflammatory effects on mesangial cells. However, further studies are required to clarify the exact mechanism by which apocynin exerts its anti-inflammatory effects via the differential suppression of MAPKs in RMCs.
Apocynin induces phosphorylation of Akt in LPS-stimulated rat mesangial cells. Given that the Akt signaling pathway is significant in cytoprotection against stresses, the effect of apocynin on Akt phosphorylation was examined. Cells were pretreated with apocynin at different concentrations for 1 h and subsequently treated with LPS (200 ng/ml) for 30 min. LPS treatment demonstrated an increased phosphorylation of Akt, which is considered to be a compensatory response to cellular damage (Fig. 4) . Apocynin treatment significantly suppressed LPS-induced phosphorylation of Akt in a concentration-dependent manner (Fig. 4) . However, apocynin, although significant, could not reverse the LPS-induced Akt phosphorylation back to the basal level. Further studies are required to clearly elucidate the exact role of Akt activation in LPS-challenged RMCs.
Apocynin induces HO-1 protein expression via Nrf2 activation in rat mesangial cells.
As HO-1 modulates inflammation and inhibits LPS-induced production of pro-inflammatory mediators, and as Nrf2, a transcription factor for HO-1, mediates major cytoprotective responses, the role of apocynin on the HO-1/Nrf2 signaling pathway was examined. RMCs were pretreated with apocynin at different concentrations for 24 h. The level of HO-1 expression was significantly increased in apocynin-treated RMCs in a concentration-dependent manner ( Fig. 5A and B) . Furthermore, apocynin exhibited increased Nrf2 phosphorylation in accordance with HO-1 expression ( Fig. 5C and D) . The data strongly indicate that apocynin exerts its anti-inflammatory activity via activation of a cellular cytoprotective pathway.
Effects of HO-1 in LPS-induced MCP-1 expression in rat mesangial cells.
To verify the cytoprotective role of apocynininduced upregulation of HO-1 on the LPS-challenged RMCs, the level of MCP-1 expression was examined in the absence and presence of HO-1 activity. RMCs were pretreated with zinc protoporphyrin (Znpp), a HO-1 inhibitor, and subsequently treated with apocynin. Following 24-h incubation with LPS, the expression level of MCP-1 was determined. In the presence of HO-1 activity, apocynin significantly attenuated LPS-induced MCP-1 expression levels in a concentration-dependent manner (Fig. 6) . However, apocynin-induced suppression of MCP-1 expression was significantly abolished in the absence of HO-1 activity with Znpp. The data strongly indicates that HO-1 mediates the apocynin-induced suppression of MCP-1 in LPS-challenged RMCs.
Discussion
In the present study, apocynin was demonstrated to significantly attenuate LPS-induced inflammatory responses via the suppression of MAPK signaling pathways, such as Erk and p38, and the activation of cytoprotective pathways, such as HO-1/Nrf2 in LPS-challenged RMCs. Apocynin suppressed LPS-induced expression of pro-inflammatory mediators, such as iNOS and COX-2. In addition, apocynin significantly attenuated LPS-induced expression of MCP-1, which was abolished with the suppression of HO-1, indicating that HO-1 mediates the suppressive effect of apocynin on MCP-1 expression in LPS-challenged RMCs. RMCs have been reported to be involved in the autoimmune glomerulonephritis (2), generation of oxygen radicals (23), and glomerular coagulation and fibrinolysis (24) . A previous study indicated that the suppression of COX-2, iNOS and NO contributes to the anti-inflammatory responses in LPS-treated human renal mesangial cells (25) . Consistently, the present study demonstrated that apocynin exerted an inhibitory effect on LPS-induced iNOS and COX-2 expression, and NO production in a concentration-dependent manner.
MCP-1-induced migration and infiltration of macrophages contributes to the aggravation of sepsis and septic shock. MCP-1, produced by mesangial cells, has been reported to contribute to the pathogenesis of glomerulonephritis (26) . The involvement of MCP-1 is not limited to glomerular inflammation, but may be observed in other inflammatory diseases. Various studies have demonstrated that MCP-1 is elevated and has a detrimental role in the development of atherosclerosis (27) , inflammatory bowel diseases (28) , rheumatoid arthritis (29) and allergic encephalitis (30) . Recently, it was reported that trihydroxycinnamic acid suppressed LPS-induced MCP-1 protein expression, resulting in the significant attenuation of LPS-induced septic renal damage (9) . In the present study, apocynin significantly inhibited LPS-induced MCP-1 expression levels in RMCs.
The present study demonstrated that among MAPKs, the phosphorylation of Erk1/2 and p38, but not JNK, was attenuated by apocynin with concurrent suppression of inflammatory responses in LPS-challenged RMCs. Previously, a similar study has demonstrated that activation of p38, Erk1/2 and Akt, in response to hydrogen peroxide, was suppressed by apocynin treatment (31) . Another consistent finding revealed that only Erk and p38 signaling pathways were involved in the induction of HO-1 (7). The Erk1/2 signaling pathway has been implicated in the development of inflammatory cellular responses in kidney injury (8) , as well as in macrophage cells (32) . The present study also indicated that Akt phosphorylation was attenuated by apocynin treatment in LPS-challenged RMCs. In the present study, activation of the Akt signaling pathway with LPS treatment was considered a compensatory response to cellular damage. Apocynin attenuated the LPS-induced Akt phosphorylation. However, further studies are required to clearly elucidate the exact role of differential suppression on MAPK and Akt signaling pathways in LPS-challenged RMCs.
Nrf-2 has been demonstrated to be key in maintaining cellular homeostasis and regulating inflammatory conditions via cytoprotective enzymes and stress-responsive proteins (33, 34) . Sulforaphane-treated mice demonstrated Nrf-2 activation and increased HO-1 expression (35) , and loss of Nrf-2 signaling increased the susceptibility to inflammation (36) . Furthermore, induction of HO-1 resulted in the reduction of oxidative stress by removing free heme, as well as an increase in the level of anti-inflammatory substances (37) . In the present study, apocynin, resulting from upregulation of the Nrf-2 signaling pathway, exhibited increased expression levels of HO-1 in RMCs. It has been reported that activation of the HO-1/Nrf-2 signaling pathway may be achieved via the various signaling pathways (10, 12, 38) . Considering the cytoprotective role of HO-1, the induction of HO-1 expression by pharmacological modulation may be a valuable therapeutic target against the progression of sepsis and inflammatory disorders. The present study demonstrated that apocynin resulted in an increase of HO-1 expression levels with subsequent attenuation of inflammation in RMCs. In addition, inhibition of HO-1 with an inhibitor, Znpp, significantly abolished apocynin-induced MCP-1 suppression in RMCs, strongly indicating that HO-1 is critically involved in the suppression of MCP-1 expression levels in RMCs. The data was consistent with previous studies demonstrating that HO-1 inducers were reported to reduce MCP-1 expression levels in sepsis and inflammatory disorders (39, 40) .
Apocynin, isolated from the root extract of Picrorhiza kurroa, has been reported to perform a range of biological activities, including radical scavenger (41) and antioxidant in vascular cells (31) , via the suppression of NADPH oxidase, which is responsible for the generation of endogenous reactive oxygen species (ROS) (42) . Apocynin has been reported to inhibit the formation of functional NADPH oxidase complex (41) . Aberrant production of NADPH-induced ROS, such as superoxide anion and hydrogen peroxide, mediates injury in various types of inflammatory disorder (41) . Furthermore, apocynin was demonstrated to provide blood pressure-lowering effects in hypertensive animals (43, 44) , as well as exerting renal protective action in rats (45) . However, the pharmacological properties of apocynin on RMCs have not been extensively elucidated in LPS-challenged RMCs. The present study is the first, to the best of our knowledge, to demonstrate that apocynin is an effective inducer of HO-1 expression in RMCs. Recently, it was reported that apocynin prevents quinolinic acid-induced neurological damage by increasing glutathione synthesis and Nrf2 mRNA expression levels (46) and that apocynin attenuates diabetes-induced adverse remodeling of left ventricular myocardium (47) , indicating the diverse therapeutic properties of apocynin.
In conclusion, the present study clearly demonstrates that apocynin may attenuate kidney dysfunction by suppressing the MCP-1-induced renal infiltration of macrophages via upregulation of the HO-1/Nrf2 signaling pathway in RMCs. In addition, apocynin significantly suppresses LPS-induced overproduction of pro-inflammatory mediators via the inhibition of aberrantly activated MAPK and Akt signaling pathways. These results demonstrate that apocynin may present as a promising candidate for in vivo evaluation of a therapeutic agent for inflammation-associated renal disorders.
